Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Parallel Session 4415

The Future of Experimental Therapeutics for Parkinson’s Disease

Monday, September 30, 2024
15:00 - 17:00 | Meeting Room 204 AB, 2nd Level
Clinical, Translational

In this session, the faculty will discuss how to design a clinical trial for testing neuroprotective treatments and the current status of drug-repurposing and gene therapies in Parkinson’s disease.

Tatyana Simuni, USA
Per Svenningsson, Sweden


Designing Trials for Neuroprotective Treatments
Margherita Fabbri, France

Repurposing Existing Drugs
Nandakumar Narayanan, USA

Gene Therapy: Bench to Bedside
Shinichi Muramatsu, Japan

CSPC Liaisons:
Shivam Mittal, United Arab Emirates

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Describe emerging approaches to testing neuroprotective treatments
  2. Recognize opportunities for repurposing existing treatments as potential neuroprotective agents
  3. Appreciate the efficacy and safety of gene-based treatments

Recommended Audience
Fellow / Resident / Student
Researcher / Basic Science

Education Level
Experienced / Intermediate
Expert / Advanced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice